About
Drug targeting A1M protein
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
360
By Phase
PHASE2: 2PHASE1: 1
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06475274Lead Sponsor
A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery
PHASE2Completed
170 participants
Started: Aug 26, 2024 · Completed: Sep 11, 2025
NCT05126303Lead Sponsor
Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery
PHASE2Terminated
177 participants
Started: Mar 31, 2022 · Completed: Jul 12, 2023
NCT04829916Lead Sponsor
A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery
PHASE1Completed
13 participants
Started: Mar 16, 2021 · Completed: Jul 15, 2021
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...